MedTrace Logo

Comparison of Regional Anesthesia Techniques After Total Knee Arthroplasty

NCT03143738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-02-28

No results posted yet for this study

Summary

Comparison of continuous adductor canal block to continuous femoral nerve block in patients after total knee arthroplasty.

All patients will be anesthetized with spinal anesthesia. Continuous infusion of ropivacaine with a catheter implemented to the adductor canal or next to the femoral nerve.

The observed goals: pain intensity, the beginning and quality of rehabilitation.

Conditions

  • Pain, Acute
  • Knee Arthropathy
  • Postoperative Pain
  • Mobility Limitation

Interventions

PROCEDURE

continuous anesthesia of adductor canal

After subarachnoid anesthesia, but before the beginning of surgery, a catheter will be implemented to the adductor canal and infusion of 5 mL/h of 0.2 % ropivacaine will be started.

PROCEDURE

continuous anesthesia of femoral nerve

After subarachnoid anesthesia, but before the beginning of surgery, a catheter will be implemented next to the femoral nerve (below inguinal ligament) and infusion of 5 mL/h of 0.2 % ropivacaine will be started.

PROCEDURE

Spinal anesthesia

Before the beginning of surgery all patients will be anesthetised with 0.5 % hyperbaric bupivacaine (Marcaine Heavy), 2.0 - 2.5 mL solution. Pencil point spinal needle will be used.

Sponsors & Collaborators

  • Konskie Specjalist Hospital

    collaborator UNKNOWN

  • Medical University of Lublin

    lead OTHER

Principal Investigators

  • Michał Borys, M.D., PhD · Medical University of Lublin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-24
Primary Completion
2018-06-30
Completion
2018-07-26

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03143738 on ClinicalTrials.gov